The Impact of Coexistence of Smoking and Diabetes on the Coronary Artery Severity and Outcomes following Percutaneous Coronary Intervention: Results from the 1ST Jordanian PCI Registry

International Journal of Vascular Medicine
Mohamad JarrahNasr Alrabadi

Abstract

Diabetes mellitus (DM) and smoking are highly prevalent among Middle Eastern patients admitted with acute coronary syndrome (ACS) or who undergo percutaneous coronary intervention (PCI). This study used the analysis of the data from the first Jordanian PCI registry (JoPCR1) to determine the impact of coexistence of smoking and diabetes mellitus on the coronary artery severity and outcome following percutaneous coronary intervention in Middle Eastern patients. Of 2426 patients enrolled, 1300 (53.6%) and 1055 (43.5%) were diabetics and smokers, respectively. The patients' age was 59.0 ± 10.1 and ranged between 24 and 95 years. Males comprised 79.4% of all patients. The patients were divided into four groups: nondiabetic-nonsmokers (22.2%), diabetic-nonsmokers (34.3%), nondiabetic-smokers (24.2%), and diabetic-smokers (19.2%). Compared with the other three groups, patients in the diabetic-nonsmoker group were older, more likely to be females, and having a higher prevalence of hypertension, dyslipidemia, chronic renal disease, and history of CVD and revascularization. Consequently, the diabetic-nonsmoker patients (but not the diabetic-smokers) had a higher prevalence of multivessel CAD and PCI than the other three groups, highlight...Continue Reading

References

May 15, 2003·Diabetes & Metabolism·G CharpentierUNKNOWN ESPOIR Diabetes Study Investigators
Jul 21, 2007·The Medical Clinics of North America·Véronique L Roger
Apr 17, 2008·Journal of Diabetes and Its Complications·Kamel AjlouniMohammed El-Khateeb
Feb 21, 2009·European Journal of Heart Failure·Andrea MortaraUNKNOWN HHH Investigators
Aug 27, 2011·International Journal of Endocrinology·Nicholaos KakourosJon R Resar
May 30, 2013·American Society of Clinical Oncology Educational Book·Graham W Warren, K Michael Cummings
Mar 25, 2014·Heart Failure Clinics·Anuradha Lala, Akshay S Desai
Sep 28, 2014·The American Journal of Medicine·Yariv GerberVéronique L Roger
Apr 1, 2015·Nature Reviews. Cardiology·Rachel Huxley
Aug 8, 2015·Circulation·Caroline S FoxUNKNOWN American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Ca
Feb 24, 2016·Circulation·J D SchwalmSalim Yusuf
Feb 22, 2017·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Firas Zahr, Joaquin E Cigarroa
Mar 16, 2017·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Enrico RomagnoliFrancesco Prati
Apr 6, 2017·Journal of Cardiovascular Pharmacology and Therapeutics·Joel P Giblett, Stephen P Hoole
Jun 7, 2017·Heart Views : the Official Journal of the Gulf Heart Association·Imad A AlhaddadUNKNOWN First Jordanian PCI Registry Investigators Group
Mar 23, 2018·Biomaterials Research·Jeong Hee LeeJoon Woo Lee
Apr 14, 2018·Journal of the American College of Cardiology·Juan TorradoLuis A Guzmán
Apr 18, 2019·The Journal of Clinical Endocrinology and Metabolism·Mayuko Yamada-HaradaHirohito Sone

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass

Software Mentioned

statistical package for social studies ( SPSS )

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.